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Abstract
We report a case of primary pararenal leiomyosarcoma involving the inferior vena cava (IVC) in a
78-year-old woman with exertional dyspnea. In the present case, we performed the tumor resection with
transient transection and primary repair of the IVC in order to avoid invasive surgery. Although the
usual treatment for younger patients is complete tumor resection with wide margins (IVC and adjacent
organs) to minimize relapse, this may be too invasive for aged patients. In this report, we discuss the
importance of minimizing the risk of complications following treatments in aged patients.
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Introduction
Primary leiomyosarcoma involving the inferior vena cava (IVC) is a rare lesion with
less than 300 cases reported. Due in part to the rarity of leiomyosarcoma of血e IVC, the
treatment regimen丘>r elderly patients has not clearly established yet. In general, the
usual treatment scheme for younger patients includes complete tumor resection with
wide margins to minimize relapse. However, it may be too invasive for aged patients.
Thus, the current report will focus on surgical management of the IVC to clarify this
issue. Here we describe the way of management in a case of primary pararenal
leiomyosarcoma involving the IVC in an elderly patient who was treated with transient
transection and primary repair of the IVC in order to avoid invasive surgery. In this
case, we describe our trial to transient transection of tumor bearing IVC segments for its
reuse for vascular reconstruction.
Case report
A 78-year-old woman with exertional dyspnea visited local hospital where helical
computed tomography (CT) of the abdomen showed an 8 × 7 cm heterogeneous mass m
contact with the medial side of the right kidney and the posterior side of the IVC (Fig.
トa). Magnetic resonance imaging (MRI) was carried out in order to evaluate the disease
extension to the adjacent major vessels more precisely丘)r the decision of the surgical
approach. MRI showed blood flow impairment of the middle and lower segments of the
IVC, which extended to the right renal vein. However, there was no thrombosis in these
segments (Fig.トb).
In this condition, an en-bloc resection including the middle and lower segments of the
IVC is usual indication. However, this type of surgery would be too invasive for an
elderly patient and would carry a high risk for many complications after the treatment.
Thus, we chose a less invasive surgical approach that would preserve the IVC. We
transected the IVC at the in丘arenal portion (Fig. 2-a, b) in order to extirpate the tumor
in the free space. The tumor widely adhered to the IVC and right renal vein grossly, but
the tumor was relatively easily teased off from the transected IVC. Following this
procedure, the resected segment of the IVC was reused for the repair of the IVC. The
operative time and amount of bleeding were 6 hours 31 minutes and 2560ml,
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respectively. The clamped time of the IVC was 57 minutes. The resected tumor was
9.3 × 8.4 × 6.5 cm in diameter and weighed 270 grams. Macrographic sections of the
specimen appeared homogeneous without hemorrhage or necrosis. Her postoperative
convalescence was uneventful without any complications. In particular, the patient did
not require long-term anticoagulant treatment since she underwent primary repair
instead of prosthetic graR replacement of the IVC.
The pathologic analyses showed that the tumor tissues comprised fascicles of
eosiophilic fusiform cells with elongated nuclei with blunt ends. Sizes of the tumor cell
nuclei vary mildly (Fig. 3 H.E.), and there were two mitoses per 10 high-power field
(Inset). Immunohistochemical analyses revealed that caldesmon and smooth muscle
actin (SMA) were positive, however s-100 protein was negative (Fig. 3). These findings
were consistent with retroperitoneal leiomyosarcoma. The surgical margins were free of
tumor. Although local recurrence occurred 12 months after the initial treatment, the
patient is alive with disease 42 months postoperatively.
Discussiom
Leiomyosarcoma involving the IVC arise from the smooth muscle cells of the vessel
wall, either from IVC itself or its branches. Due to its rarity, optimal management and
long-term outcomes are not yet well described. Aggressive surgical management should
be attempted for complete excision whenever possible. However, leiomyosarcoma is
reported to have a poor prognosis. The overall survival of patients with tumors in all
segments of the IVC is 49.4% in 5 years and 29.5% in lOyears, despite complete
resection of the tumors with wide free margins. Local recurrence occurred in 33% of
the patients, and distant recurrence occurred in 48% of the patients. After aggressive
surgical resection, the IVC could be managed using primary repair, ligation, or
prosthetic graft. Each procedure has different merits and demerits. For patients of
advanced age, the postoperative quality of life (QOL) is especially important since they
carry a higher risk for major complications following the invasive surgery which may
be lethal. When we choose operative procedures, the cases should be assessed
individually to determine the best strategy to reconstruct the IVC丘)r a better prognostic
outcome m young patients and to lower the risk of complications in elderly patients.
In fact, there is considerable controversy about the type of caval reconstruction to
perform as a treatment for leiomyosarcoma with reference to the patient's age, tumor
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location and size, and involvement of adjacent organs. Several authors recommend
prosthetic replacement, but others often perform cavoplasty or ligation of the IVC3-6
The type of IVC resection should be tailored individually depending on the
topographic tumor expansion. Circumferential IVC resection with graft replacement in
particular requires long-term anticoagulant treatment for preventing thrombus formation.
If good patency of the graft could not be maintained at the renal vein portion of the IVC,
renal failure and leg edema would be induced. In our case, the elderly patient did not
require long-term anticoagulant treatment due to the transient transection of the IVC at
the infrarenal portion and primary repair instead of prosthetic graft replacement of the
IVC.
Our report shows that it is important to minimize the risk of complications following
treatments for leiomyosarcoma of the IVC in aged patients.
Figure legend
Figure 1-a :
The contrast enhanced CT of the abdomen showed an 8 × 7 cm heterogeneous mass
which compressed the IVC toward to the anterior side.
Figure 1-b :
MRI did not show the disease extension to the adjacent major vessels and the
intramural space of the IVC.
Figure 2-a : Intraoperative views
The IVC was compressed anteriorly. Dissection of the tumor from the IVC was
deemed difficult, thus transient transection of the IVC was performed to remove the
tumor.
Figure 2-b : Schematic presentation of the tumor resection.
Figure 3 : Histopathological findings (magnification of all pictures, × 100)
The tumor tissues showed eosiophilic fusiform cells forming fascicles. There were a
few mitoses (Inset). Immunohistochemical stains for caldesmon and smooth muscle
actin (SMA) were positive, however s- 1 00 protein was negative.
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